How Neurizon raised $17.8m by directly engaging 20% of their shareholder base.
Dr Michael Thurn (CEO) maximised investor attention and demand throughout a capital raise.
- Industry
- Biotechnology
Problem
Companies struggle to identify and capitalise on latent investor demand during a raise.
Impact
Neurizon raised $17.8m in total, with $7.8m via a heavily oversubscribed SPP (3.9x the original target) and 20% of the register participating.
- 9 months
- With InvestorHub
- $17.8m
- Capital raised
- 3.9x
- More capital than target
- 8.3k
- Unique investors engaged
20% of our share registry participated in the capital raise. The $17.8m we've raised gives us the funding and confidence to pursue our objectives.
Explore more case studies
AusQuest Limited (ASX:AQD)
Maximising the impact of good newsflow with AusQuest.
A proactive approach to engaging the market supported a 560% increase in share price (460% from pre-InvestorHub).
Read the case studyKalgoorlie Gold Mining (ASX:KAL)
Building a compelling project narrative with Kalgoorlie Gold.
Communicating throughout the project lifecycle. A discovery resulted in a 400% increase in share price (157% from pre-InvestorHub).
Read the case studyRareX Limited (ASX:REE)
How RareX saved $100k in broker fees while raising $1.5m.
RareX's CEO used InvestorHub to raise capital with a 0% discount directly from shareholders.
Read the case studyTake control of your register
See how InvestorHub helps listed companies close the distance to their shareholders.